Christopher Kemball
Senior Principal Scientist, Genentech
Christopher Kemball is listed as Senior Principal Scientist, Genentech. Christopher is scheduled to speak at Festival of Biologics USA on 14 April 2027.
Compiled from published conference agendas; not yet confirmed by Christopher. Is this you? Claim this profile.
About
Christopher Kemball received a B.A. in Biochemical Sciences from Harvard University and a Ph.D. in Immunology & Microbial Pathogenesis from Emory University. He conducted postdoctoral research at The Scripps Research Institute and investigated how coxsackievirus impairs antiviral T cell immunity and modifies cellular autophagy. Chris joined Agensys, Inc. in 2011 as a scientist and led preclinical research programs focused on bispecific antibodies and next-generation antibody drug conjugates. Chris joined Genentech, Inc. in 2018 and is a Senior Principal Scientist in the Department of Biochemical & Cellular Pharmacology, supporting in vitro characterization of therapeutics for oncology and immunology.